Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Guerrieri

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Oncotarget|August 20, 2015
Exercise-mimetic AICAR transiently benefits brain functionDavide Guerrieri, Henriette van Praag
Brain Plasticity (Amsterdam, Netherlands)|May 17, 2018
Exercise in a Pill: The Latest on Exercise-MimeticsDavide Guerrieri, Hyo Youl Moon, Henriette van Praag
Journal of Analytical Toxicology|September 15, 2018
Validation and Cross-Reactivity Data for Fentanyl Analogs With the Immunalysis Fentanyl ELISADavide Guerrieri, Fanny Kjellqvist, Robert Kronstrand, et al.
Forensic Science International|June 8, 2017
Acrylfentanyl: Another new psychoactive drug with fatal consequencesDavide Guerrieri, Emma Rapp, Markus Roman, et al.
Handbook of Experimental Pharmacology|August 15, 2018
Fatal Poisonings Associated with New Psychoactive SubstancesRobert Kronstrand, Davide Guerrieri, Svante Vikingsson, et al.
Forensic Science International|November 7, 2020
In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT<sub>1A</sub>, and 5-HT<sub>2A</sub> receptors-On-target receptor potency and efficacy, and off-target effectsAnna Åstrand, Davide Guerrieri, Svante Vikingsson, et al.
Journal of Analytical Toxicology|January 19, 2017
Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related DeathsDavide Guerrieri, Emma Rapp, Markus Roman, et al.
Experimental Parasitology|December 5, 2012
Biochemical effects of riluzole on Leishmania parasitesDavide Guerrieri, Stefania Ferrari, M Paola Costi, et al.
Bioanalysis|December 18, 2024
Simultaneous isotyping and semi-quantitation of anti-drug antibodies to an IgG1 biotherapeutic using hybrid LBA-LC-MS/MSFrank B Schalk, Davide Guerrieri, Johann Poetzl, et al.
Bioanalysis|November 30, 2023
Signal-to-noise ratio to assess magnitude, kinetics and impact on pharmacokinetics of the immune response to an adalimumab biosimilarDavide Guerrieri, Matej Horvat, Jamie Fan, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Oncotarget|August 20, 2015
Exercise-mimetic AICAR transiently benefits brain functionDavide Guerrieri, Henriette van Praag
Brain Plasticity (Amsterdam, Netherlands)|May 17, 2018
Exercise in a Pill: The Latest on Exercise-MimeticsDavide Guerrieri, Hyo Youl Moon, Henriette van Praag
Journal of Analytical Toxicology|September 15, 2018
Validation and Cross-Reactivity Data for Fentanyl Analogs With the Immunalysis Fentanyl ELISADavide Guerrieri, Fanny Kjellqvist, Robert Kronstrand, et al.
Forensic Science International|June 8, 2017
Acrylfentanyl: Another new psychoactive drug with fatal consequencesDavide Guerrieri, Emma Rapp, Markus Roman, et al.
Handbook of Experimental Pharmacology|August 15, 2018
Fatal Poisonings Associated with New Psychoactive SubstancesRobert Kronstrand, Davide Guerrieri, Svante Vikingsson, et al.
Forensic Science International|November 7, 2020
In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT<sub>1A</sub>, and 5-HT<sub>2A</sub> receptors-On-target receptor potency and efficacy, and off-target effectsAnna Åstrand, Davide Guerrieri, Svante Vikingsson, et al.
Journal of Analytical Toxicology|January 19, 2017
Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related DeathsDavide Guerrieri, Emma Rapp, Markus Roman, et al.
Experimental Parasitology|December 5, 2012
Biochemical effects of riluzole on Leishmania parasitesDavide Guerrieri, Stefania Ferrari, M Paola Costi, et al.
Bioanalysis|December 18, 2024
Simultaneous isotyping and semi-quantitation of anti-drug antibodies to an IgG1 biotherapeutic using hybrid LBA-LC-MS/MSFrank B Schalk, Davide Guerrieri, Johann Poetzl, et al.
Bioanalysis|November 30, 2023
Signal-to-noise ratio to assess magnitude, kinetics and impact on pharmacokinetics of the immune response to an adalimumab biosimilarDavide Guerrieri, Matej Horvat, Jamie Fan, et al.
Pageof 3